JP2006514683A5 - - Google Patents

Download PDF

Info

Publication number
JP2006514683A5
JP2006514683A5 JP2005501095A JP2005501095A JP2006514683A5 JP 2006514683 A5 JP2006514683 A5 JP 2006514683A5 JP 2005501095 A JP2005501095 A JP 2005501095A JP 2005501095 A JP2005501095 A JP 2005501095A JP 2006514683 A5 JP2006514683 A5 JP 2006514683A5
Authority
JP
Japan
Prior art keywords
seq
pharmaceutical composition
composition according
inflammation
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2005501095A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006514683A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2003/031562 external-priority patent/WO2004032850A2/en
Publication of JP2006514683A publication Critical patent/JP2006514683A/ja
Publication of JP2006514683A5 publication Critical patent/JP2006514683A5/ja
Pending legal-status Critical Current

Links

JP2005501095A 2002-10-07 2003-10-07 ヒトｚｖｅｎアンタゴニストの使用 Pending JP2006514683A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US41671802P 2002-10-07 2002-10-07
US41671902P 2002-10-07 2002-10-07
US43411602P 2002-12-16 2002-12-16
US43391802P 2002-12-16 2002-12-16
US50861403P 2003-10-03 2003-10-03
US50860303P 2003-10-03 2003-10-03
PCT/US2003/031562 WO2004032850A2 (en) 2002-10-07 2003-10-07 Uses of human zven antagonists

Publications (2)

Publication Number Publication Date
JP2006514683A JP2006514683A (ja) 2006-05-11
JP2006514683A5 true JP2006514683A5 (https=) 2006-11-16

Family

ID=32097184

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2005501095A Pending JP2006514683A (ja) 2002-10-07 2003-10-07 ヒトｚｖｅｎアンタゴニストの使用

Country Status (6)

Country Link
US (16) US7291589B2 (https=)
EP (1) EP1558287A4 (https=)
JP (1) JP2006514683A (https=)
AU (2) AU2003295343A1 (https=)
CA (2) CA2500772A1 (https=)
WO (2) WO2004031367A2 (https=)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7883872B2 (en) 1996-10-10 2011-02-08 Dyadic International (Usa), Inc. Construction of highly efficient cellulase compositions for enzymatic hydrolysis of cellulose
KR100618495B1 (ko) 1998-10-06 2006-08-31 마크 아론 에말파브 섬유상의 진균성 숙주 영역에서의 형질전환 시스템:크리소스포륨속에서
US6485938B1 (en) * 1999-11-16 2002-11-26 Zymogenetics, Inc. Nucleic acid molecules that encodes human Zven1
US20040235732A1 (en) * 2000-11-03 2004-11-25 Qun-Yong Zhou Method for modulating angiogenesis using prokineticin receptor antagonists
WO2004032851A2 (en) 2002-10-04 2004-04-22 The Regents Of The University Of California Screening and therapeutic methods relating to neurogenesis
JP2006514683A (ja) * 2002-10-07 2006-05-11 ザイモジェネティクス，インコーポレイティド ヒトｚｖｅｎアンタゴニストの使用
JP4912144B2 (ja) * 2003-03-12 2012-04-11 ジェネンテック， インコーポレイテッド 造血促進のためのｂｖ８及び／又はｅｇ−ｖｅｇｆの使用
KR20080006564A (ko) 2005-03-24 2008-01-16 얀센 파마슈티카 엔.브이. 프로키네티신 1 수용체 길항제
JP2008537548A (ja) * 2005-03-24 2008-09-18 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ プロキネチシン１受容体
CA2622575A1 (en) 2005-09-13 2007-03-22 Zymogenetics, Inc. Prok2 antagonists and methods of use
WO2007079163A2 (en) 2005-12-29 2007-07-12 Janssen Pharmaceutica N.V. Prokineticin 1 receptor antagonists
EP2505651A3 (en) 2006-12-10 2013-01-09 Dyadic International, Inc. Isolated fungus with reduced protease activity
WO2008121046A1 (en) * 2007-03-29 2008-10-09 Forskarpatent I Syd Ab Improvement of gastric emptying in patients suffering from diabetes mellitus
US20100286021A1 (en) * 2007-09-25 2010-11-11 Qun-Yong Zhou Methods of Modulating Prokineticin 2 for Treatment of Stress Response and Anxiety-Related Disorders
US11650213B2 (en) * 2015-03-30 2023-05-16 Entvantage Diagnostics, Inc. Devices and assays for diagnosis of viral and bacterial infections

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4756479A (en) * 1987-04-06 1988-07-12 Lazenby Iii George I Flush hydrant
US5294630A (en) * 1992-07-07 1994-03-15 Eli Lilly And Company Treatment of inflammatory bowel disease
US6042821A (en) * 1995-11-21 2000-03-28 Smithkline Beecham Corporation Method of treating sepsis with chemokines
US5891720A (en) * 1997-04-17 1999-04-06 Millennium Pharmaceuticals, Inc. Isolated DNA encoding a novel human G-protein coupled receptor
JP2001512013A (ja) 1997-08-01 2001-08-21 ジェンセット 前立腺に発現される分泌タンパク質の５’ｅｓｔ
CA2328895A1 (en) 1998-06-02 1999-12-09 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US7264801B2 (en) * 1998-08-11 2007-09-04 Genentech, Inc. EG-VEGF nucleic acids and polypeptides and method of use
US20020172678A1 (en) * 2000-06-23 2002-11-21 Napoleone Ferrara EG-VEGF nucleic acids and polypeptides and methods of use
US6284725B1 (en) * 1998-10-08 2001-09-04 Bionebraska, Inc. Metabolic intervention with GLP-1 to improve the function of ischemic and reperfused tissue
AU5151100A (en) 1999-05-19 2000-12-05 Incyte Genomics, Inc. Extracellular signaling molecules
US6485938B1 (en) * 1999-11-16 2002-11-26 Zymogenetics, Inc. Nucleic acid molecules that encodes human Zven1
WO2001036465A2 (en) * 1999-11-16 2001-05-25 Zymogenetics, Inc. Human zven proteins
CA2394749A1 (en) * 1999-12-28 2001-07-05 Pharmacia & Upjohn Company G protein-coupled receptors
EP1302542B1 (en) 2000-07-18 2007-06-13 Takeda Pharmaceutical Company Limited Novel physiologically active peptide and use thereof
EP1506971A1 (en) * 2000-11-03 2005-02-16 The Regents of the University of California Prokineticin polypeptides, related compositions and methods
JP2004532609A (ja) 2000-11-03 2004-10-28 ザ リージェント オブ ザ ユニバーシティ オブ カリフォルニア プロキネチシンポリペプチド、関連組成物および方法
US6671555B2 (en) * 2001-04-27 2003-12-30 Medtronic, Inc. Closed loop neuromodulation for suppression of epileptic activity
AU2002359351A1 (en) 2001-11-02 2003-05-19 Nuvelo, Inc. Methods and materials relating to prokineticin-like polypeptides and polynucleotides
EP1581648A2 (en) * 2002-09-09 2005-10-05 Nura, Inc. G protein coupled receptors and uses thereof
JP2006514683A (ja) * 2002-10-07 2006-05-11 ザイモジェネティクス，インコーポレイティド ヒトｚｖｅｎアンタゴニストの使用
WO2004065419A1 (ja) 2003-01-22 2004-08-05 Takeda Pharmaceutical Company Limited 抗体およびその用途
JP4912144B2 (ja) 2003-03-12 2012-04-11 ジェネンテック， インコーポレイテッド 造血促進のためのｂｖ８及び／又はｅｇ−ｖｅｇｆの使用
US7115560B2 (en) * 2003-03-25 2006-10-03 The Regents Of The University Of California Methods for modulating gastric secretion using prokineticin receptor antagonists
US20070014799A1 (en) 2003-10-22 2007-01-18 Takeda Pharmaceutical Company Limited Antibody and use of the same
CA2622575A1 (en) * 2005-09-13 2007-03-22 Zymogenetics, Inc. Prok2 antagonists and methods of use

Similar Documents

Publication Publication Date Title
JP2006514683A5 (https=)
US12410256B2 (en) Antibodies that specifically bind to TL1a and methods of treating gastrointestinal or lung diseases
JP2012012402A5 (https=)
RU2701434C2 (ru) Связывающие белки и способы их применения
Dammacco et al. Clinical practice: hepatitis C virus infection, cryoglobulinemia and cryoglobulinemic vasculitis
Stoop et al. Antibodies specific for carbamylated proteins precede the onset of clinical symptoms in mice with collagen induced arthritis
JP2007535912A5 (https=)
HRP20201323T1 (hr) Protutijela koja se specifično vežu na tl1a
JP6081699B2 (ja) Ｉｌ−２８ｂの分析方法
US20190391163A1 (en) Tissue-specific exosomes as biomarkers
JP2014518883A5 (https=)
JP2009541204A5 (https=)
EA012464B1 (ru) Антитело против cd20 и его применение
PT2734549T (pt) Anticorpo monoclonal contra interleucina-31 canina
JP2011518773A5 (https=)
JP2010043063A (ja) 川崎病の診断及び治療
US20240034757A1 (en) Tick chemokine binding proteins for use in therapy and diagnosis
KR20180094877A (ko) 아밀로이드 베타 내 c-말단 에피토프 및 이에 대해 구조적으로 선택적인 항체
JP2016539925A5 (https=)
JP2007526891A5 (https=)
JP2014509860A5 (https=)
JP2022501389A5 (https=)
JP2005507648A5 (https=)
EP3423079A1 (en) Evasins for use in therapy and diagnostics
JP2007508020A5 (https=)